Hannah Everitt

Hannah Everitt is a seasoned clinical operations manager with extensive experience in the pharmaceutical industry. Currently, Hannah serves as the Manager of Clinical Operations at Alnylam Pharmaceuticals since December 2018, having previously held roles such as Clinical Trial Manager and Managed Access Programme Manager at WEP Clinical. Prior positions include Clinical Project Manager at P1vital and Director at Ansley Pharma Solutions Limited. Hannah's expertise encompasses ensuring clinical trial ethics approvals and managing essential document collections and quality control during trial processes. Academic credentials include a Master of Science in Toxicology from the University of Birmingham and a PhD focused on liver function impact from alcohol intake, undertaken at the University of Westminster.